Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic Syndrome
City of Hope Medical Center
City of Hope Medical Center
Syndax Pharmaceuticals
CareDx
Center for International Blood and Marrow Transplant Research
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
AstraZeneca
MEI Pharma, Inc.
Center for International Blood and Marrow Transplant Research
City of Hope Medical Center
Sellas Life Sciences Group
AvenCell Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
Janssen Research & Development, LLC
University of Miami
Gyala Therapeutics
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Caribou Biosciences, Inc.
Massachusetts General Hospital
AbbVie
M.D. Anderson Cancer Center
University of Oklahoma
City of Hope Medical Center
University of Chicago
St. Jude Children's Research Hospital
Orca Biosystems, Inc.
Baptist Health South Florida
Tempus AI
Fred Hutchinson Cancer Center
Case Comprehensive Cancer Center
Gamida Cell ltd
Servier
Ossium Health, Inc.
Ossium Health, Inc.
Orca Biosystems, Inc.
Children's Hospital of Philadelphia
City of Hope Medical Center
Dartmouth-Hitchcock Medical Center
Children's Hospital Medical Center, Cincinnati
Essen Biotech
M.D. Anderson Cancer Center
Ege University
Institute of Hematology & Blood Diseases Hospital, China
University of Washington
Center for International Blood and Marrow Transplant Research
Center for International Blood and Marrow Transplant Research
Alliance for Clinical Trials in Oncology